As of July 2025, according to Mettler Toledo International's current financial statements, the company's 12-month EPS is $40.23. Mettler Toledo International's EPS for 2024 amounted to $40.67, marking an increase from $36.1 in 2023. Mettler Toledo International's earnings per share for the quarterly report ending on Mar 31, 2025 reached $7.84.
The annual EPS for the year 2024 was $40.67, an increase of 12.7% from $36.1 in 2023. The quarterly per-share earnings for the period ending Mar 31, 2025, was $7.84, indicating a 5.3% decrease from the same quarter last year. MTD's 12-month EPS stands at $40.23 as of March 2025. Mettler Toledo International's annual EPS in 2023 stood at $36.1, a 6.9% decrease year-over-year.
During the last 12 months, Mettler Toledo International has seen an EPS growth of -5.3% (YoY, quarterly). Throughout the last three years, the company had an average EPS growth of 6.9% per year. During the last 5 years, the company had an average EPS growth rate of 12.2%. When measured over a ten-year period, MTD's average EPS growth rate was 13.3%.
Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
---|---|---|---|---|
WAT Waters Corp | 27.39 | -1.1% | -1.5% | 4.2% |
TMO Thermo Fisher Scientific Inc | 27.99 | 6.8% | -5.5% | 12.4% |
MTD Mettler Toledo International Inc | 31.42 | 12.7% | 6.9% | 12.2% |
XYL Xylem Inc | 35.64 | 30.6% | 15.7% | 10.5% |
DHR Danaher Corp | 43.44 | -17.2% | -15.3% | 5.3% |
BRKR Bruker Corp | 80.65 | -74% | -25.4% | -9.8% |
BIO Bio-Rad Laboratories Inc | N/A | -199.5% | N/A | N/A |
HBIO Harvard Bioscience Inc | N/A | -250% | N/A | N/A |
All data is based on quarterly TTM periods, unless otherwise specified.